期刊文献+

银杏达莫联合甲钴胺治疗糖尿病周围神经病变32例 被引量:8

Combined treatment of flavonoids and mecobalamin on diabetic peripheral neuropathy in 32 diabetics
下载PDF
导出
摘要 目的观察银杏达莫联合甲钴胺治疗糖尿病周围神经病变的临床疗效。方法对64例糖尿病周围神经病变患者随机分为两组,治疗组和对照组各32例,治疗组银杏达莫联合甲钴胺治疗,对照组单用甲钴胺治疗,比较两组疗效。结果治疗组总有效率87.5%,与对照组68.8%比较,差异有统计学意义(P<0.05)。结论银杏达莫注射液与注射用甲钴胺联合治疗,疗效优于对照组,且安全有效,值得临床推广。
作者 王霞
出处 《河南科技大学学报(医学版)》 2010年第2期88-89,共2页 Journal of Henan University of Science & Technology:Medical Science
  • 相关文献

参考文献6

二级参考文献37

  • 1汤晓英 杨秉贤 等.运动及感觉神经传导速度测定在糖尿病性神经病早期诊断中的价值[J].中华神经精神杂志,1982,15:78-78.
  • 2[3]King GL. Abnormalities of the vascular endothelium in diabetes.Diabetes Annu, 1993,7: 107.
  • 3[4]Verrotti A, Giuva PT, Morgese G, et al. New trends in the etiopathogenesis of diabetic peripheral neuropathy. J Child Neurol,2001,16(6) :389~394.
  • 4[5]Jensen PG, Larson JR. Management of painful diabetic neuropathy. Drugs Aging, 2001,18(10) :737~749.
  • 5[6]Cameron NE, Cotter MA. Diabetes causes an early reduction in autonomic ganglion blood flow in rats. J Diabetes Complications,2001,15(4): 198~202.
  • 6Cameron NE,Eaton SE,Cotter MA,et al.Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy.Diabetologia,2001,44:1973~1988.
  • 7Cameron NE,Cotter MA.Metabolic and vascular factors in the pathogenesis of diabetic neuropathy.Diabetes,1997,46(2):31~37.
  • 8Vinik AL,Park TS,Stansberry KB.Diabetic neuropathies.Diabetologia,2000,43:957~973.
  • 9Zochodne DW.Diabetic neuropathies:features and mechanisms.Brain Pathol,1999,9(2):369~391.
  • 10Vasan S,Foiles PG,Founds HW.Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links.Expert-Opin-Investig Drugs,2001,10:1977~1987.

共引文献2464

同被引文献84

引证文献8

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部